15876-67-2
15876-67-2 structure
- Name: distigmine bromide
- Chemical Name: (1-methylpyridin-1-ium-3-yl) N-methyl-N-[6-[methyl-(1-methylpyridin-1-ium-3-yl)oxycarbonylamino]hexyl]carbamate,dibromide
- CAS Number: 15876-67-2
- Molecular Formula: C22H32Br2N4O4
- Molecular Weight: 576.32
- Catalog: Research Areas Neurological Disease
- Create Date: 2018-02-23 08:00:00
- Modify Date: 2024-01-02 14:32:49
-
Ubretid is a potent inhibitor of plasma cholinesterase. Ubretid therefore delays the hydrolysis of suxamethonium and prolongs its action, similar to the effects shown by other anticholinesterase drugs, such as pyridostigmine and donepezil. Ubretid has the potential for the research of urinary retention prolongs the effect of suxamethonium. Ubretid is commonly prescribed for the research of myasthenia gravis and for difficulty in emptying the bladder[1].
| Name | (1-methylpyridin-1-ium-3-yl) N-methyl-N-[6-[methyl-(1-methylpyridin-1-ium-3-yl)oxycarbonylamino]hexyl]carbamate,dibromide |
|---|---|
| Synonyms |
Distigminbromid
EINECS 240-013-0 Distigmindibromid Bromure de distigmine [INN-French] Hexamethylenebis[N-methylcarbaminoyl-1-methyl-3-hydroxypyridinium Bromide] Hexamethylenebis[methylcarbamic Acid] Ester of 3-Hydroxy-1-methylpyridinium Bromide 3,3'-{Hexane-1,6-diylbis[(methylcarbamoyl)oxy]}bis(1-methylpyridinium) dibromide Ubretid Distigmine 3,3'-{1,6-Hexanediylbis[(methylcarbamoyl)oxy]}bis(1-methylpyridinium) dibromide N,N'-Dimethyl-N,N'-bis-(1-methyl-pyridinium-3-yloxycarbonyl)-hexandiyldiamin,Dibromid N,N'-dimethyl-N,N'-bis-(1-methyl-pyridinium-3-yloxycarbonyl)-hexanediyldiamine,dibromide Hexamethylenebis[N-methylcarbamic Acid Ester Bromomethylate] Hexamarium Pyridinium, 3,3'-[1,6-hexanediylbis[(methylimino)carbonyloxy]]bis[1-methyl-, bromide (1:2) 3-Hydroxy-1-methylpyridinium Bromide Hexamethylenebis[methylcarbamate] Ubritil distigmine bromide BC 51 Distigmini bromidum [INN-Latin] Bromuro de distigmina [INN-Spanish] 3,3'-[1,6-Hexanediylbis[(methylimino)carbonyl]oxy]bis[1-methylpyridinium]dibromide |
| Description | Ubretid is a potent inhibitor of plasma cholinesterase. Ubretid therefore delays the hydrolysis of suxamethonium and prolongs its action, similar to the effects shown by other anticholinesterase drugs, such as pyridostigmine and donepezil. Ubretid has the potential for the research of urinary retention prolongs the effect of suxamethonium. Ubretid is commonly prescribed for the research of myasthenia gravis and for difficulty in emptying the bladder[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C22H32Br2N4O4 |
|---|---|
| Molecular Weight | 576.32 |
| Exact Mass | 574.079041 |
| PSA | 66.84000 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
|
~%
15876-67-2 |
| Literature: US2789981 , ; |
| Precursor 1 | |
|---|---|
| DownStream 0 | |